Bioprocessing

Weight loss is often celebrated as a definitive victory for personal health, yet new research suggests that the journey toward a lower number on the scale can sometimes compromise the body’s internal foundation. Ivan Kairatov, a distinguished biopharma expert with extensive experience in research

The medical landscape of South Texas is undergoing a profound transformation as specialized clinicians at Methodist Healthcare pioneer the transition of chimeric antigen receptor T-cell therapy from a niche oncological intervention to a versatile therapeutic platform for complex diseases.

Ivan Kairatov has spent decades at the center of biopharmaceutical innovation, specializing in the high-stakes world of respiratory research and development. His expertise in dissecting the clinical and strategic failures of major drug candidates has made him a leading voice for investors and

The frontier of synthetic biology has moved beyond the mere editing of existing organisms toward the radical construction of entirely new life forms from inanimate chemical components. For decades, the primary strategy involved stripping genetic material from bacteria until only the essentials

The landscape of oncology has reached a pivotal juncture where terminal diagnoses for aggressive blood cancers are increasingly being redefined by the success of durable, long-term immunotherapy outcomes. Recent five-year clinical data for lisocabtagene maraleucel, commonly referred to as liso-cel,

The global manufacturing landscape is currently undergoing a radical transformation as industries seek to replace traditional petroleum-dependent processes with sustainable, bio-based alternatives that utilize engineered microorganisms. This paradigm shift, often referred to as biomanufacturing,